Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya

Sponsor
Centers for Disease Control and Prevention (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01695304
Collaborator
Kenya Medical Research Institute (Other)
227
1
2
17
13.4

Study Details

Study Description

Brief Summary

The aim of the study is to examine the efficacy of ceramic water filters to reduce the burden of waterborne diarrheal illness among infants in selected villages in Kenya. In Kenya very young children are given drinking water or water is used in reconstitution of their food. We hypothesize that ceramic water filters will remove Cryptosporidium from drinking water reducing infection in infants.

Condition or Disease Intervention/Treatment Phase
  • Other: Ceramic water filter
N/A

Detailed Description

Diarrhea is a major cause of illness among children in Africa. Cryptosporidium is a protozoan waterborne diarrheal pathogen resistant to chlorine. Ceramic filters are effective at improving drinking water quality, including removal of protozoa. In a recent preliminary analysis of >22,000 children <5 years enrolled in the Global Enterics Multi-Center Study (GEMS) case-control study of moderate-to-severe diarrhea, Cryptosporidium was identified as a leading cause of diarrhea in infants across all four participating African sites. This pilot is the first Cryptosporidium specific intervention trial of household ceramic water filters to reduce the burden of cryptosporidiosis acquired through drinking water in rural Kenya.

Study Design

Study Type:
Interventional
Actual Enrollment :
227 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
This is an intervention trial of ceramic water filters, and as such cannot be masked. The intervention participants received the CWFs during the trial and the control group after the trial was over.
Primary Purpose:
Prevention
Official Title:
Pilot Intervention Trial of Ceramic Water Filters to Reduce the Burden of Cryptosporidium in Household Drinking Water in Rural Kenya.
Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Aug 1, 2013
Actual Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Arm

Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water.

Other: Ceramic water filter
In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends.
Other Names:
  • Cera Maji ceramic water filter
  • No Intervention: Control Arm

    Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends.

    Outcome Measures

    Primary Outcome Measures

    1. Longitudinal Diarrhea Prevalence [6 months]

      The primary outcome measure is the longitudinal prevalence of diarrheal disease.

    2. Health Facility Visits for Diarrheal Disease [6 months]

      incidence rate of health facility visits for diarrheal disease per 100 person-week of observation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Months to 10 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Children 4-10 months old living in selected villages in the Asembo Health and Demographic Surveillance System (HDSS) study area in Kenya whose primary caretakers consent on their behalf to be visited weekly for 6 months to carry out weekly illness surveillance, and have a follow up home visit one year after initial enrollment into the trial. The household in which the child resides must be a consenting participant in the HDSS. As the children included in the trial are infants, the child's primary caretaker will be invited to participate and be administered questionnaires. Random selection will be at the compound level. Only one household per compound will be eligible for selection.

    Exclusion Criteria:

    Children 4-10 months old whose households are not active consenting participants in the HDSS will not be eligible for inclusion. Only the subset of children 4-10 months old who are randomly selected in the sample will be eligible for participation.

    -

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kemri/Cdc Kisumu Kenya

    Sponsors and Collaborators

    • Centers for Disease Control and Prevention
    • Kenya Medical Research Institute

    Investigators

    • Principal Investigator: Eric Mintz, MD, MPH, Centers for Disease Control and Prevention

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centers for Disease Control and Prevention
    ClinicalTrials.gov Identifier:
    NCT01695304
    Other Study ID Numbers:
    • CDC-NCEZID-6369
    • CDCEID10A.1
    • 2439
    First Posted:
    Sep 27, 2012
    Last Update Posted:
    Mar 22, 2017
    Last Verified:
    Sep 1, 2015
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Centers for Disease Control and Prevention
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Intervention Arm Control Arm
    Arm/Group Description Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends.
    Period Title: Overall Study
    STARTED 120 120
    COMPLETED 120 120
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title Intervention Arm Control Arm Total
    Arm/Group Description Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. Total of all reporting groups
    Overall Participants 120 120 240
    Age (months) [Median (Full Range) ]
    Median (Full Range) [months]
    7
    8
    7.5
    Sex: Female, Male (Count of Participants)
    Female
    66
    55%
    62
    51.7%
    128
    53.3%
    Male
    54
    45%
    58
    48.3%
    112
    46.7%
    Race/Ethnicity, Customized (participants) [Number]
    Luo ethnic group
    120
    100%
    120
    100%
    240
    100%
    Region of Enrollment (participants) [Number]
    Kenya
    120
    100%
    120
    100%
    240
    100%

    Outcome Measures

    1. Primary Outcome
    Title Longitudinal Diarrhea Prevalence
    Description The primary outcome measure is the longitudinal prevalence of diarrheal disease.
    Time Frame 6 months

    Outcome Measure Data

    Analysis Population Description
    Incidence rate per 100 person-weeks of observation
    Arm/Group Title Intervention Arm Control Arm
    Arm/Group Description Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends.
    Measure Participants 115 112
    Number [Incidence rate per 100 person-weeks]
    7.6
    8.9
    2. Primary Outcome
    Title Health Facility Visits for Diarrheal Disease
    Description incidence rate of health facility visits for diarrheal disease per 100 person-week of observation
    Time Frame 6 months

    Outcome Measure Data

    Analysis Population Description
    incidence rate of health facility visits for diarrheal disease per 100 person-week of observation
    Arm/Group Title Intervention Group Control Group
    Arm/Group Description Intervention group who received ceramic water filters Control Group who did not receive ceramic water filters (until after the trial ended)
    Measure Participants 115 112
    Number [incidence rate per 100 person-weeks]
    1.2
    2.2

    Adverse Events

    Time Frame 6 months
    Adverse Event Reporting Description
    Arm/Group Title Intervention Arm Control Arm
    Arm/Group Description Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends.
    All Cause Mortality
    Intervention Arm Control Arm
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 2/120 (1.7%) 3/120 (2.5%)
    Serious Adverse Events
    Intervention Arm Control Arm
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/120 (0%) 0/120 (0%)
    Other (Not Including Serious) Adverse Events
    Intervention Arm Control Arm
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/120 (0%) 0/120 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Ciara O'Reilly, PhD
    Organization Centers for Disease Control and Prevention
    Phone 404-639-1953
    Email bwf1@cdc.gov
    Responsible Party:
    Centers for Disease Control and Prevention
    ClinicalTrials.gov Identifier:
    NCT01695304
    Other Study ID Numbers:
    • CDC-NCEZID-6369
    • CDCEID10A.1
    • 2439
    First Posted:
    Sep 27, 2012
    Last Update Posted:
    Mar 22, 2017
    Last Verified:
    Sep 1, 2015